NorthWest Biotherapeutics Inc (NWBO)

[austinmediainc]

None of those are fundamental to the trial. The screening halt may be a positive. In any case, events are accruing and enough patients are enrolled. They don't need 348. 330 is just as good.

The finances are a product of the market and have nothing to do we success of the trial.

Come on Reefrad, they are all fundamental to the trial. The screening halt may be positive, but it may not be and that's why it is fundamental. The finances are very important to the trial and the company, if they don't have the finances they can't afford to finish or keep the trial going and the trial ends! This is not fundamental?

The fundamentals aren't based on your personal opinion, it has to do with the most important factors that affect the company and or trial.

"forming a necessary base or core; of central importance"